References
1. Vincent J-L, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. J Am Med Assoc 2009;302:2323–9.10.1001/jama.2009.1754Search in Google Scholar
2. Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998;244:379–86.10.1046/j.1365-2796.1998.00379.xSearch in Google Scholar
3. Roberts J, Paul S, Akova M, Bassetti M, De Waele J, Dimopoulos G, et al. DALI: defining antibiotic levels in intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients. Clin Infect Dis 2014;58:1072–83.10.1093/cid/ciu027Search in Google Scholar
4. Roberts J, Lipman J. Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 2009;37:840–51.10.1097/CCM.0b013e3181961bffSearch in Google Scholar
5. Roberts JA, Ulldemolins M, Roberts MS, McWhinney B, Ungerer J, Paterson DL, et al. Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept. Int J Antimicrob Agents 2010;36:332–9.10.1016/j.ijantimicag.2010.06.008Search in Google Scholar
6. De Waele JJ, Carrette S, Carlier M, Stove V, Boelens J, Claeys G, et al. Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial. Intens Care Med 2014;40:380–7.10.1007/s00134-013-3187-2Search in Google Scholar
7. Verdier MC, Tribut O, Tattevin P, Le Tulzo Y, Michelet C, Bentue-Ferrer D. Simultaneous determination of 12 beta-lactam antibiotics in human plasma by high-performance liquid chromatography with UV detection: application to therapeutic drug monitoring. Antimicrob Agents Chemother 2011;55:4873–9.10.1128/AAC.00533-11Search in Google Scholar
8. Beumier M, Casu GS, Hites M, Seyler L, Cotton F, Vincent J-L, et al. Beta-lactam antibiotic concentrations during continuous renal replacement therapy. Crit Care 2014;18:R105.10.1186/cc13886Search in Google Scholar
9. Doh K, Woo H, Hur J, Yim H, Kim J, Chae H, et al. Population pharmacokinetics of meropenem in burn patients. J Antimicrob Chemother 2010;65:2428–35.10.1093/jac/dkq317Search in Google Scholar
10. Forgue ST, Pittman KA, Barbhaiya RH. High-performance liquid chromatographic analysis of a novel carbapenem antibiotic in human plasma and urine. J Chromatogr 1987;414:343–53.10.1016/0378-4347(87)80059-2Search in Google Scholar
11. Carlier M, Stove V, Roberts JA, Van de Velde E, De Waele JJ, Verstraete AG. Quantification of seven β-lactam antibiotics and two β-lactamase inhibitors in human plasma using a validated UPLC-MS/MS method. Int J Antimicrob Agents 2012;40:416–22.10.1016/j.ijantimicag.2012.06.022Search in Google Scholar PubMed
©2015 by De Gruyter
